Loading...

Home
ETF
EDIT

EDIT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

EDIT News

Q32 Bio Soars Over 85% on $55 Million Private Placement Announcement

3d agoNASDAQ.COM

Editas Medicine Prices Public Offering of 55.6 Million Shares

4d agoNASDAQ.COM

Editas Medicine Prices Public Offering at $2.25 per Share

5d agoNewsfilter

Editas Medicine Launches Public Offering, Shares Drop Nearly 12%

5d agoseekingalpha

Editas Medicine Launches Underwritten Public Offering

5d agoNewsfilter

Editas Medicine Unveils New Data on EDIT-401 for Hyperlipidemia

May 14 2026Newsfilter

Editas Medicine Q1 Earnings Report Analysis

May 05 2026seekingalpha

Editas Medicine Announces Multiple Conference Presentations

Apr 27 2026Newsfilter

Editas Medicine Wins CRISPR Patent Dispute Favoring Broad Institute

Mar 27 2026NASDAQ.COM

Editas Medicine Faces Ongoing Decline Risks

Mar 17 2026Fool

Editas Medicine Q4 Earnings Beat Expectations

Mar 09 2026seekingalpha

Three Genomics Stocks Worth Adding to Your Portfolio

Nov 18 2025NASDAQ.COM

Janux Therapeutics, Inc. (JANX) Announces Q3 Loss but Exceeds Revenue Projections

Nov 07 2025NASDAQ.COM

Gene Editing Therapy Firms Surge Following News of Simplified FDA Approval Process

Oct 31 2025SeekingAlpha

Intellia Halts Major Trial Following Severe Liver Incident, Shares Plummet

Oct 27 2025Benzinga

After-Hours Surge Boosts PALI, HCTI, NTRB, KPTI, EDIT, and CGON Amid Mixed News and Strategic Actions

Oct 10 2025NASDAQ.COM